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Abstract  
Introduction: Epilepsy is common in sub-Saharan Africa, but there is little data in West Africa, to develop public health measures for epilepsy in 
this region. Methods: We conducted a three-stage cross-sectional survey to determine the prevalence and risk factors for active convulsive 
epilepsy (ACE), and estimated the treatment gap in Kintampo situated in the middle of Ghana. Results: 249 people with ACE were identified in a 
study population of 113,796 individuals. After adjusting for attrition and the sensitivity of the screening method, the prevalence of ACE was 
10.1/1000 (95% Confidence Interval (95%CI) 9.5-10.7). In children aged <18 years, risk factors for ACE were: family history of seizures 
(OR=3.31; 95%CI: 1.83-5.96), abnormal delivery (OR=2.99; 95%CI: 1.07-8.34), problems after birth (OR=3.51; 95%CI: 1.02-12.06), and 
exposure to Onchocerca volvulus (OR=2.32; 95%CI: 1.12-4.78). In adults, a family history of seizures (OR=1.83; 95%CI: 1.05-3.20), never 
attended school (OR=11.68; 95%CI: 4.80-28.40), cassava consumption (OR=3.92; 95%CI: 1.14-13.54), pork consumption (OR=1.68; 95%CI: 
1.09-2.58), history of snoring at least 3 nights per week (OR=3.40: 95%CI: 1.56-7.41), exposure to Toxoplasma gondii (OR=1.99; 95%CI: 1.15-
3.45) and Onchocerca volvulus (OR=2.09: 95%CI: 1.29-3.40) were significant risk factors for the development of ACE. The self-reported treatment 
gap was 86.9% (95%CI: 83.5%-90.3%). Conclusion: ACE is common within the middle belt of Ghana and could be reduced with improved 
obstetric care and prevention of parasite infestations such as Onchocerca volvulus and Toxoplasma gondii. 
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Introduction 
 
Epilepsy is one of the most common neurological disorders 
worldwide, contributing one percent to the global burden of disease 
[1, 2]. About 69 million people worldwide are affected by this 
disorder with 90 percent of these individuals living in low- and 
middle-income countries [3]. In Africa, there are inadequate data on 
the burden, risk factors, and treatment gap on which to plan public 
health interventions. A review of the epidemiology and aetiology of 
epilepsy in sub-Saharan Africa (SSA) documented many descriptive 
studies of the aetiology of epilepsy, but only a few case-control 
studies [2, 4]. Most studies did not provide electroencephalography 
(EEG) or neuroimaging data. There are several population-based 
case-control studies in SSA [5-15] as well as more descriptive 
studies [16-20], that have highlighted the considerable 
heterogeneity in the prevalence of epilepsy and incidence of risk 
factors for epilepsy in the region. Parasitic infestations, such as 
Onchocerca volvulus, Taenia solium and Toxoplasma gondii are 
believed to increase the risk of epilepsy [21, 22], and these 
infections are common in most parts of SSA. Large community-
based studies are needed to confirm these possible relationships, 
and to plan preventive/intervention measures. This study estimated 
the prevalence of, and identified risk factors for active convulsive 
epilepsy (ACE) in the two districts of Ghana with a Health and 
Demographic Surveillance Systems (HDSS). The study was 
conducted as part of a multi-site and multi-country study of ACE in 
SSA [6].  
  
  
Methods 
 
Study design : a cross-sectional and case control studies was 
conducted to identify cases of ACE in the study area of the 
Kintampo Health Research Centre located in the middle belt of 
Ghana. This survey formed part of a large multi-centre study 
investigating the epidemiology of epilepsy in five sites in Africa with 
a HDSS, and was conducted between June 2010 and April 2011.  
  
Study area: the study was carried out in the study area of 
Kintampo Health Research Centre (KHRC), which is located in the 
geographical middle of Ghana. The study area has a surface area of 
7,162 square kilometers with the current resident population 
approximately 140,000 [23]. The main indigenous ethnic groups of 
the area are the Bonos and the Mos. There is, however, a large 
immigrant population mainly of Dagaabas, Dagombas and 
Konkombas from the three northern regions of Ghana as well as Ga 
Adangbes and Ewes with origins from southern Ghana. Twi is the 
commonest language spoken in the studied area. Community 
members engage in farming, predominantly of maize, yam and 
cassava. Livestock rearing of cattle, sheep, goats and poultry is also 
common, and some of the southerners fish on the Volta Lake. The 
vegetation is mainly of the forest-savannah transition type. There 
are two main seasons: the rainy season, which usually, start from 
March to November, and the dry season from December to February 
each year. The area is endemic for malaria [24] and onchocerciasis 
and some risk factors for toxocara and onchocerciasis are socio-
economical [25]. The Kintampo Municipal Hospital and Jema 
Hospital are the two government hospitals in the Kintampo North 
Municipality and Kintampo South district respectively. They both 
have outpatient and inpatient facilities. The only psychiatric wing, 
manned by psychiatric nurses, is however, in the Kintampo North 
Municipal Hospital.  
  
The Survey Tools: the study questionnaires on socio-demographic 
variables and historical risk factors for epilepsy [6] were translated 
into the widely-spoken local language (Twi) in the study area and 
finalised during training and pre-testing by project staff.  
  
Identification of cases of ACE : a multistage approach was used 
to identify cases of ACE and has been published elsewhere [6]. In 
brief, KHRC maintains a Kintampo Demographic Surveillance System 
that has a database of all inhabitants of the study area. Firstly 
(Stage I), all members of the KHDSS population were screened for 
convulsion or fits using a two-item questionnaire administered by 
trained census fieldworkers [26]. The respondent was mainly the 
head or an adult member who have an in-depth knowledge about 
the household. During this stage, we sought to identify all people 
who had experienced a seizure in their lifetime. Secondly (Stage II), 
further detailed screening with a ten-question epilepsy questionnaire 
was administered by trained field supervisors who went to potential 
cases identified in the initial stage as ever having history of 
convulsion. At this stage, if the patient had at least two convulsions 
within their lifetime, with one in the last twelve months, he/she was 
referred to stage III for clinical evaluation and confirmation of ACE. 
Thirdly (Stage III), participants socio-demographic data was 
collected from caregivers. Clinical evaluation was performed by a 
trained clinician who made a diagnosis of ACE based upon a positive 
clinical history. The clinical examination focused at neurological 
deviations and blood was drawn from all patients for serological 
testing. The diagnosis of ACE was confirmed by a neurologist 
through the review of all information about the patient.  
  
Identification of controls: age-matched controls (i.e. community 
members who did not have epilepsy) were randomly chosen from 
the Kintampo HDSS (KHDSS) database. Risk factors were 
determined using a questionnaire administered by a fieldworker to 
both cases of ACE and controls. Blood samples were taken from 
both cases and controls to determine exposure to parasitic 
infections (Onchocerca volvulus, Taenia solium, Plasmodium 
falciparum (schizont), Toxocara canis, Toxoplasma gondii) and HIV 
status. Exposure to infections was determined by detection of IgG 
antibodies to the parasitic antigens as well as HIV [27].  
  
Population Sample : a random sample of 5000 participants from 
the KHDSS were interviewed in stage II alongside the stage I 
positives from the census survey. This was done to compare the 
prevalence estimate from the two-stage method with that from the 
main three-stage study (Figure 1).  
  
Statistical Analysis: data were double entered and verified in 
MySQL Version 5 open source database (Oracle Corporation, 
Redwood Shores, CA, USA) and all statistical analyses were carried 
out in STATA Version 11 (StataCorp, College Station, TX, USA). An 
unadjusted prevalence of ACE and 95% confidence interval (95%CI) 
was estimated as the number of cases of ACE confirmed in Stage III 
of the study divided by the total population screened in Stage I, 
expressed per 1,000 persons. Age, sex and sub-district specific 
prevalence of ACE were also estimated. Multiple imputation [28, 29] 
was used to reduce bias in the prevalence estimates due to attrition 
between stages in both the two- and three-stage surveys. Missing 
data were imputed at each stage of the survey using the outcome 
of the previous stage. Multiple imputation was carried out using the 
method of chained equations which was implemented using the 
“ice”command in STATA. The prevalence estimate was divided by 
0.486 to account for the sensitivity (48.6%) of the three-stage 
screening methodology [30]. We report association between ACE, 
age, sex and sub-district. For each risk factor adjusted odd ratio 
(OR) were obtained by fitting logistic regression models that 
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included age, sex, education (none, primary, or secondary and 
above), employment, marital status, and country as covariates as 
well as the risk factor of interest. Age was modelled as a fractional 
polynomial of degree two.  
  
Ethical Approvals: written informed consent was obtained from all 
study participants. Unique reference codes were used to replace 
personal identifiers to ensure anonymity. Ethical approval was 
obtained from the Ghana Health Service Ethics Review Committee 
(Federal wide Assurance number -(FWA) 00020025), the Kintampo 
Health Research Centre Institutional Ethics Committee (FWA 
number 00011103) and the Ethics Committee of the Institute of 
Child Health, University College, London.  
  
  
Results 
 
Characteristics of the study population: a total of 113,796 out 
of the 129,812 individuals in the KHDSS population (i.e. 87.7%) 
were screened in stage I. About 12.3% (16,016) of the targeted 
population in stage I were not met after three consecutive visits 
either migrated out of the study area or could not be found by the 
census fieldworkers. About 2.9% (3,344) of participants identified in 
stage I with history of convulsions of which 570 (17.9% of those 
positive in stage I) met the stage II referral criteria and were 
referred to the study clinic for detail clinical and neurological 
assessment (Figure 1). There were 20 individuals that were 
positive in stage II of the survey but who were missed by census 
fieldworkers in stage I. In stage III, 443 individuals were assessed, 
of whom 249 (56.2%) persons were confirmed as having ACE. The 
rest of the stage II referrals had febrile seizures. Demographic 
characteristics of the studied population are shown in Table 1.  
  
The prevalence of Epilepsy in the KHDSS population: the 
prevalence of convulsions in the entire KHDSS population was 
29.2/1000 (95%CI: 28.3-30.2). The crude prevalence of ACE per 
1000 people was 2.2/1000 (95%CI: 1.9-2.5), 4.9/1000 (95%CI: 
4.4-5.3) when adjusted for attrition and 10.1/1000 (95%CI: 9.5-
10.7) when adjusted for attrition and sensitivity. Males had higher 
prevalence of ACE (11.1/1000, 95%CI: 9.7-12.3) compared with 
females (9.1/1000, 95%CI: 7.8-10.3). The crude prevalence of ACE 
was highest in Kunsu, Jema and lowest in Kintampo sub districts 
(Table 2).  
  
Age of onset of ACE: the median age of onset of seizures was 8.0 
(Interquartile Range, 2.8-15.0) years, and the median duration of 
seizures was 10.2 (Interquartile Range, 4.7-16.1) years.  
  
Risk Factor Analysis: the analysis used data from 381 controls 
and 392 cases; 249 cases identified by the three-stage method and 
143 cases identified from other sources including referrals during 
stage II screening, community members and health staff. In the 
logistic regression model for children below 18 years of age, family 
history of seizures (OR=3.31; 95%CI: 1.83-5.96), abnormal delivery 
(OR=2.99; 95%CI: 1.07-8.34), problems after birth (OR=3.51; 
95%CI: 1.02-12.06), difficulties in feeding, crying or breathing after 
birth (OR=73.04; 95%CI: 9.81-544.07), and Onchocerca volvulus 
(OR=2.32; 95%CI: 1.12-4.78), were all significant risk factors for 
the onset of ACE (Table 3). Among adults, family history of 
seizures (OR=1.83; 95%CI: 1.05-3.20), history of no schooling 
(OR=11.68; 95%CI: 4.80-28.40), problems after birth (OR=8.74; 
95%CI: 3.21-23.83), cassava consumption (OR=3.92; 95%CI: 1.14-
13.54), pork consumption (OR=1.68; 95%CI: 1.09-2.58), history of 
snoring at least 3 nights / week) (OR=3.40: 95%CI: 1.56-7.41), 
Toxoplasma gondii IgG +ve (OR=1.99; 95%CI: 1.15-3.45) and 
onchocerca volvulus +ve (OR=2.09: 95%CI: 1.29-3.40) were all 
important risk factors for the development of ACE (Table 4)  
  
  
Discussion 
 
The study describes the prevalence as well as the risk factors for 
ACE in the Kintampo districts located in the middle belt of Ghana. 
ACE is noted to be widespread in the area with heterogeneity across 
the sub-districts. Antenatal/perinatal risk factors were associated 
with ACE in children and parasitic infections with adults.  
  
Prevalence: the high prevalence of ACE reported in this study is 
similar to estimates from other countries in the sub-region [6, 9-11, 
13] and within the range estimated for ACE in other low-income 
countries [6]. The prevalence was slightly higher among males 
compared with females. This finding has been reported in other 
studies [16] and might be due to greater risk taking behaviour of 
males compared with females even though head injury was not a 
significant risk factor in this study.  
  
Geographical Heterogeneity: there crude prevalence of ACE 
varied across the sub-districts in the study area (Table 2). Apart 
from Kunsu sub-district, which is part of the Kintampo North 
municipality, the six sub-districts with the highest prevalence of ACE 
are situated in the Kintampo South district. There are many factors 
which may explain this difference. Firstly, there are fewer medical, 
particularly neurological services available in the South. Also, there 
are less Muslims in the Kintampo South compared with the 
Kintampo North, and since Muslims do not keep pigs or eat pork, 
this may contribute to explaining why there are fewer cases of ACE 
in this area. Jema and Kintampo that are nearer the main hospitals 
(Table 2) have a higher prevalence of ACE compared with other 
sub-districts. People with ACE in this area may be more likely to 
survive compared to other areas. This could be due to a more 
supervised delivery, early presentation and management of risk 
factors, e.g. treatment for parasitic infection among those closer to 
health facilities. Also routine deworming among school children is 
less likely to be effective among children in remote or sub-districts 
where school enrollment is usually low. In the adjoining district to 
Kintampo South district the prevalence of Onchocerca volvulus is 
high, where over 50% of the population lived in areas with a 
community microfilarial load in excess of 10 mf/snip [31] even 
though vector control programme have reduced transmission [32]. 
This may explain the relatively high prevalence of ACE in the 
Kintampo South District than in the Kintampo North Municipality.  
  
Risk factors for ACE: there was a significant association between 
a history of family seizures and ACE. This association has been 
reported by Prischich et al. [16]. Nevertheless, the effect of family 
history might be overestimated because people with active epilepsy 
may be more aware of other family members who are affected by 
seizures compared with those who do not have epilepsy. Also, 
people with ACE may have similar exposure to parasitic infections 
compared with those who do not have epilepsy. Antenatal 
difficulties (Table 3) were associated with the development of active 
epilepsy. Studies have reported that birth asphyxia is a preventable 
risk factor for epilepsy [6, 33]. The percentage of home deliveries in 
Ghana is now 42% [34], and home deliveries in Kintampo is about 
30% [35]. Onchocerciasis infection might be a risk factor for the 
development of ACE in adults within the study area since other 
studies have found an association between onchocerciasis and 
epilepsy [22, 36, 37]. However, it is also possible that people with 
epilepsy have increased exposure to parasites compared with those 
who do not just because of their vulnerability. There have been a 
number of programmes in West Africa, including Ghana, for the 
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control and eradication of onchocerciasis [38]. In Ghana, vector 
control has virtually ceased, except limited activities associated with 
the construction of the Bui Dam, a hydroelectric dam located within 
71.4 KM of the study area [39, 40]. Resistant adult parasite 
populations, which were not responding as expected to ivermectin, 
have emerged [41, 42]. A high rate of repopulation of skin with 
microfilariae will allow parasite transmission, possibly with 
ivermectin-resistant O. volvulus, which could eventually lead to 
recrudescence of the disease [41]. Further research is needed to 
improve monitoring and establish thresholds that determine when 
control is needed. In this study, history of head injury, exposure to 
infections such as malaria (as measured by schizont antibodies), 
taenia and HIV were not significant risk factors for the development 
of active convulsive epilepsy. Kintampo is a malaria endemic area 
[43] so that nearly everybody is exposed to malaria. Other parasitic 
infections such as toxocara and toxoplasmosis have been 
documented elsewhere to be associated with epilepsy [44-46], even 
though their relationship with epilepsy in SSA has not been properly 
documented [44]. The prevalence of taenia and head injury is 
relatively low in this study even though other studies in West Africa, 
such as Nigeria have reported an association between head injury 
and epilepsy [8, 45, 46]. This study found consumption of cassava 
to be significantly associated with active epilepsy in adults. Our 
study area is predominantly rural and many inhabitants cultivate 
rooted carbohydrate crops such as cassava and yam. Cassava 
consumption might be a marker of poverty which is strongly 
associated with ACE, but cassava consumption maybe related to 
ACE through malnutrition. This risk might be due to the 
consumption of freshly uprooted cassava which has a high 
concentration of cyanide compared to a day or two after uprooting 
[47]. Surprisingly, snoring at least three times per night in a week 
was a risk factor for developing active epilepsy. Some studies have 
reported the presence of snoring among epileptic patients [48, 49]. 
Previous studies have reported association of obstructive sleep 
apnea and epilepsy [50].  
  
Limitations of the study: as the respondents were asked to recall 
exposure to risk factors in the past, this could have resulted in recall 
bias of some of the risk factors such as abnormal delivery, 
difficulties feeding, crying or breathing after birth. Having been 
involved in previous clinical trials, the community has been 
sensitised to recall of health-related issues and may not be far from 
being correct in the recalls made in this study.  
  
  
Conclusion 
 
Epilepsy is a common neurological disorder in this part of Ghana. 
Active convulsive epilepsy is associated with family history of 
epilepsy, history of snoring, perinatal difficulties and parasitic 
infection. The major preventable risk factors for children are 
perinatal and post natal difficulties and exposure to Onchocerca 
volvulus. Adult preventable risk factors included no formal 
education, problems after birth, cassava and pork consumption, and 
parasitic infections such as T. gondii and O. volvulus. Adequate and 
proper prenatal care aimed at avoiding problems during pregnancy 
and perinatal measures could reduce complications that may result 
in epilepsy. Also, control measures for onchocerciasis and the 
strengthening of the health systems to include information about 
the risk factors for ACE in their outreach programmes could reduce 
the prevalence of epilepsy in Ghana.  
  
Future Research: there is the need to conduct further studies on 
the incidence of ACE, excess mortality in people diagnosed as 
having ACE, and the risk factors for death among people with ACE. 
Also, the relationship between snoring and epilepsy, cassava 
consumption and epilepsy need to be investigated.  
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Table 1: age and sex distribution of study populations, 2011 
Age-group No % 
 0-5 17,424 15.3 
6-12 23,124 20.3 
13-18 17,021 15.0 
19-28 18,843 16.6 
29-49 23,091 20.3 
50+ 14,286 12.6 
Sex     
Female 57,888 50.9 
Male 55,908 49.1 
Highest Education     
None 62,356 54.8 
Primary 19,750 17.4 
Middle/continuation, JSS, 20,544 18.1 
Technical, commercial, SSS 6,094 5.4 
Post-middle college: Teacher, training, secretarial 223 0.2 
Post-secondary: Nursing, teacher, polytechnic 4,498 3.95 
University 331 0.29 
Total 113,796 100 
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Table 3: regression analysis of risk factors for ACE in Children (<18 years) 
 
% % Unadjusted Adjusted 
Risk Factor Controls Cases OR (95% CI) p-value OR (95% CI) p-value 
Family history of 
seizure 
14.0(24/172) 30.8(44/143) 2.74(1.52,5.02) 0.0003 3.31(1.83,5.96) <0.001 
Maternal seizures  0.6(1/172) 1.4(2/144) 2.41(0.12,142.89) 0.593 2.92(0.26,32.81) 0.386 
Abnormal delivery  3.7(6/164) 9.2(13/141) 2.67(0.91,8.80) 0.057 2.99(1.07,8.34) 0.036 
Abnormal antenatal 
period  
11.5(19/165) 17.8(24/135) 1.66(0.83,3.38) 0.138 1.87(0.94,3.75) 0.075 
Home delivery  71.3(119/167) 79.6(113/142) 1.57(0.90,2.77) 0.113 1.47(0.85,2.55) 0.173 
Problems after birth  2.4(4/164) 7.7(11/142) 3.36(0.96,14.75) 0.036 3.51(1.02,12.06) 0.047 
Difficulties feeding, 
crying or breathing  
0.6(1/164) 31.6(43/136) 75.37(12.27,3062.68) <0.001 73.04(9.81,544.07) <0.001 
Head injury  18.7(32/171) 25.0(36/144) 1.45(0.82,2.57) 0.216 1.45(0.82,2.54) 0.2 
Malnourished  20.8(32/154) 12.5(15/120) 0.54(0.26,1.11) 0.077 0.56(0.28,1.12) 0.102 
 
Eats cassava  100.0(170/170) 96.5(138/143) 0.00(0.00,0.63) 0.019 1.00(1.00,1.00) 
  
Dogs in household  48.3(83/172) 47.6(68/143) 0.97(0.61,1.55) 0.91 0.93(0.58,1.50) 0.777 
Cats in household  33.1(57/172) 34.3(49/143) 1.05(0.64,1.73) 0.905 0.97(0.59,1.58) 0.896 
Eats Pork  51.2(88/172) 53.8(77/143) 1.11(0.70,1.78) 0.652 1.12(0.70,1.78) 0.646 
Malaria IgG +ve 
(schizont)  
99.1(116/117) 100.0(93/93) NA 1 NA NA 
Hospitalised with 
malaria or fever  
0.0(0/173) 0.0(0/145) NA NA NA NA 
Toxocara canis 
IgG4 +ve  
13.7(16/117) 14.0(13/93) 1.03(0.43,2.42) 1 0.97(0.42,2.24) 0.935 
Toxoplasma gondii 
IgG +ve  
42.7(50/117) 51.6(48/93) 1.43(0.80,2.56) 0.213 1.06(0.58,1.94) 0.852 
Taenia solium +ve  6.9(8/116) 4.3(4/93) 0.61(0.13,2.36) 0.554 0.40(0.10,1.66) 0.207 
Onchocerca 
volvulus +ve  
16.2(19/117) 33.3(31/93) 2.58(1.28,5.26) 0.005 2.32(1.12,4.78) 0.023 
HIV +ve  20.5(24/117) 25.8(24/93) 1.35(0.67,2.71) 0.41 1.35(0.67,2.73) 0.395 
Odds ration adjusted for: age, sex, maternal education, maternal marital status and employment of either parent. Fisher’s exact test for 
unadjusted p-values. 
 
 
 
 
Table 2: crude prevalence of ACE and parasitic infection by sub-district in the Kintampo area, 2011 
Sub-District Population No of 
cases 
Prevalence per 
1000 people 
(95% CI) 
Onchocerca 
volvulus 
Toxoplasma 
gondii 
Toxocara canis 
% control % control % control 
Amoma 12,922 40 3.1 (2.2 - 4.2) 60.0(15/25) 48.0(12/25) 88.0(22/25) 
Anyima 7,972 16 2.0 (1.1 - 3.3) 33.3(7/21) 57.1(12/21) 71.4(15/21) 
Apesika 11,008 33 3.0 (2.1 - 4.2) 35.5(11/31) 71.0(22/31) 87.1(27/31) 
Busuama 4,708 5 1.1 (0.3 - 2.5) 0.0(0/4) 100.0(4/4) 75.0(3/4) 
Dawadawa 6,043 6 1.0 (0.4 - 2.2) 22.7(5/22) 68.2(15/22) 81.8(18/22) 
Gulumpe 9,170 10 1.1 (0.5 - 2.0) 61.5(8/13) 61.5(8/13) 84.6(11/13) 
Jema 19,204 60 3.1 (2.4 - 4.0) 34.6(28/81) 67.9(55/81) 81.5(66/81) 
Kadelso 5,073 10 2.0 (0.9 - 3.6) 25.0(6/24) 58.3(14/24) 70.8(17/24) 
Kintampo 38,797 22 0.6 (0.4 - 0.9) 30.2(19/63) 60.3(38/63) 73.2(46/63) 
Kunsu 6,146 26 4.2 (2.8 - 6.2) 52.6(10/19) 63.2(12/19) 94.7(18/19) 
Mansie 5,367 15 2.8 (1.6 - 4.6) 50.0(2/4) 75.0(3/4) 100.0(4/4) 
New Longoro 3,402 6 1.8 (0.6 - 3.8) 0.0(0/1) 0.0(0/1) 100.0(1/1) 
Total 129,812 249 1.9 (1.7 - 2.2)       
The denominators may not be the same as the number of cases because of missing data on Onchocerca volvulus, Toxoplasma gondii and 
Toxocara canis status. Also the controls were not matched to cases on sub-district hence the number of controls in some sub-districts is greater 
than the number of cases 
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 Table 4: regression analysis of risk factors for ACE in Adult (≥18 years) 
 
% % Unadjusted Adjusted 
Risk Factor Controls Cases OR (95% CI) p-value OR (95% CI) p-value 
Family history of seizure 13.0(27/207) 24.8(60/242) 2.20(1.30,3.77) 0.002 1.83(1.05,3.20) 0.034 
Maternal seizures  0.0(0/207) 0.4(1/243) NA 1 NA NA 
Abnormal delivery  8.1(16/198) 6.7(16/239) 0.82(0.37,1.80) 0.586 0.82(0.36,1.90) 0.646 
       
Never Attended School 35.5 (72/203) 63.3(124/249) 2.4(1.67 – 3.39) <0.001 11.68(4.80, 28.40) <0.001 
Home delivery  85.6(167/195) 86.0(208/242) 1.03(0.57,1.82) 1 1.07(0.58,1.99) 0.824 
       
Problems after birth  3.1(6/196) 18.3(44/240) 7.11(2.92,20.82) <0.0001 8.74(3.21,23.83) <0.001 
Head injury  4.3(9/208) 6.1(15/245) 1.44(0.58,3.82) 0.529 1.26(0.49,3.21) 0.633 
Drinks alcohol  24.1(49/203) 27.3(66/242) 1.18(0.75,1.85) 0.514 1.51(0.91,2.52) 0.111 
Eats cassava  93.2(193/207) 98.0(240/245) 3.48(1.16,12.54) 0.017 3.92(1.14,13.54) 0.031 
Eats Pork  41.3(86/208) 49.0(119/243) 1.36(0.92,2.01) 0.108 1.68(1.09,2.58) 0.018 
History of Snoring (3 
nights /week) 
25.2(41/303) 74.8(122/249) 5.0 (3.34 – 7.56) <0.001 3.40(1.56,  7.41) 0.002 
Uses drugs  1.9(4/206) 4.5(11/242) 2.40(0.70,10.50) 0.187 2.80(0.78,10.14) 0.116 
Hypertension  2.5(5/202) 0.0(0/243) 0.00(0.00,0.63) 0.019 NA NA 
Stroke  0.0(0/202) 0.0(0/243) NA NA NA NA 
Diabetes mellitus  0.5(1/201) 0.0(0/243) 0.00(0.00) 0.453 NA NA 
Malnourished  17.5(34/194) 18.6(41/221) 1.07(0.63,1.83) 0.8 0.97(0.53,1.77) 0.923 
Dogs in household  49.5(103/208) 43.9(107/244) 0.80(0.54,1.17) 0.256 0.90(0.59,1.37) 0.616 
Cats in household  30.3(63/208) 36.1(88/244) 1.30(0.86,1.97) 0.23 1.28(0.82,2.00) 0.275 
Malaria IgG +ve (schizont)  100(175/175) 99.5(187/188) 0.00(0.00) 1 NA NA 
Hospitalised with malaria 
or fever  
0.0(0/208) 0.0(0/245) NA NA NA NA 
Toxocara canis IgG4 +ve  20.6(36/175) 24.5(46/188) 1.25(0.74,2.12) 0.383 1.26(0.72,2.21) 0.411 
Toxoplasma gondii IgG+ve  67.4(118/175) 81.9(154/188) 2.19(1.31,3.68) 0.002 1.99(1.15,3.45) 0.014 
Taenia solium +ve  4.0(7/174) 3.7(7/188) 0.92(0.27,3.15) 1 0.83(0.24,2.93) 0.774 
Onchocerca volvulus +ve  32.0(56/175) 50.5(95/188) 2.17(1.39,3.41) 0.0004 2.09(1.29,3.40) 0.003 
HIV +ve  30.9(54/175) 29.3(55/188) 0.93(0.58,1.49) 0.819 0.76(0.45,1.28) 0.303 
Odds ratio adjusted for: age, sex, education, marital status and employment. Fisher’s exact test for unadjusted p-values. 
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Figure 1: study Flow chart showing the numbers at each stage of the study, 2011 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
